Clearmind Medicine, Inc. (CMND)
1.64
0.00 (0.00%)
USD |
NASDAQ |
Jul 22, 09:42
Clearmind Medicine Gross Profit (TTM) : -0.0526M for April 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| April 30, 2026 | -0.0526M |
| January 31, 2026 | -0.0507M |
| October 31, 2025 | -0.0494M |
| July 31, 2025 | -0.048M |
| April 30, 2025 | -0.0507M |
| January 31, 2025 | -0.0545M |
| October 31, 2024 | -0.0511M |
| July 31, 2024 | -0.0436M |
| April 30, 2024 | -0.0463M |
| January 31, 2024 | -0.0412M |
| October 31, 2023 | -0.0545M |
| July 31, 2023 | -0.0775M |
| April 30, 2023 | -0.1063M |
| January 31, 2023 | -0.0998M |
| October 31, 2022 | -0.0874M |
| July 31, 2022 | -0.0625M |
| April 30, 2022 | -0.0158M |
| January 31, 2022 | -0.0116M |
| Date | Value |
|---|---|
| October 31, 2021 | -0.002M |
| July 31, 2021 | 0.00 |
| April 30, 2021 | 0.00 |
| January 31, 2021 | 0.00 |
| October 31, 2020 | 0.00 |
| July 31, 2020 | 0.00 |
| April 30, 2020 | 0.00 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| InMed Pharmaceuticals, Inc. | 0.5836M |
| NervGen Pharma Corp. | -0.0404M |
| Milestone Pharmaceuticals, Inc. | 1.627M |
| Pharmagreen Biotech, Inc. | -0.001M |
| Lexaria Bioscience Corp. | 0.095M |